Long-term effects of maternal deprivation on cholinergic system in rat brain

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Marković, Branka ^a   Radonjić, Nevena V ^a   Aksić, Milan ^a   Filipović, Branislav ^a   Petronijević, Nataša ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CHOLINERGIC NERVE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FOREBRAIN; HIPPOCAMPAL CA1 REGION; LONG TERM EXPOSURE; MALE; MATERNAL DEPRIVATION; NONHUMAN; PERINATAL PERIOD; RAT; RETROSPLENIAL CORTEX; SCHIZOPHRENIA; WISTAR RAT; ANIMAL; BIOSYNTHESIS; CHOLINERGIC NERVE CELL; ENZYMOLOGY; HIPPOCAMPUS; LIFE EVENT; METABOLISM; PATHOLOGY;

ACETYLCHOLINESTERASE; ANIMALS; CHOLINERGIC FIBERS; CHOLINERGIC NEURONS; FEMALE; HIPPOCAMPUS; LIFE CHANGE EVENTS; MALE; MATERNAL DEPRIVATION; RATS;

EID: 84897473637     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/636574     Document Type: Article

References (51)

1. Koehl M., Lemaire V., Vallée M., Abrous N., Piazza P. V., Mayo W., Maccari S., Le Moal M., Long term neurodevelopmental and behavioral effects of perinatal life events in rats. Neurotoxicity Research 2001 3 1 65 83 2-s2.0-0034900654 (Pubitemid 32717296)
2. Viveros M.-P., Díaz F., Mateos B., Rodríguez N., Chowen J. A., Maternal deprivation induces a rapid decline in circulating leptin levels and sexually dimorphic modifications in hypothalamic trophic factors and cell turnover. Hormones and Behavior 2010 57 4-5 405 414 2-s2.0-77950936826 10.1016/j.yhbeh.2010.01.009
3. Walker E. F., Diforio D., Schizophrenia: a neural diathesis-stress model. Psychological Review 1997 104 4 667 685 2-s2.0-0031255540 (Pubitemid 127499376)
4. Ellenbroek B. A., Cools A. R., The neurodevelopmental hypothesis of schizophrenia: clinical evidence and animal models. Neuroscience Research Communications 1998 22 3 127 136 (Pubitemid 28305949)
5. Bramon E., Kelly J., van Os J., Murray R. M., The cascade of increasingly deviant development that culminates in the onset of schizophrenia. NeuroScience News 2001 4 1 5 19 2-s2.0-0034972846 (Pubitemid 32550283)
6. Foster D. J., Jones C. K., Conn P. J., Emerging approaches for treatment of schizophrenia: modulation of cholinergic signaling. Discovery Medicine 2012 14 79 413 420
7. King D. J., Drug treatment of the negative symptoms of schizophrenia. European Neuropsychopharmacology 1998 8 1 33 42 2-s2.0-0031962988 10.1016/S0924-977X(97)00041-2 (Pubitemid 28012858)
8. Tandon R., Shipley J. E., Greden J. F., Mann N. A., Eisner W. H., Goodson J.-A., Muscarinic cholinergic hyperactivity in schizophrenia. Relationship to positive and negative symptoms. Schizophrenia Research 1991 4 1 23 30 2-s2.0-0026025726 10.1016/0920-9964(91)90006-D
9. Freedman R., Olincy A., Buchanan R. W., Harris J. G., Gold J. M., Johnson L., Allensworth D., Guzman-Bonilla A., Clement B., Ball M. P., Kutnick J., Pender V., Martin L. F., Stevens K. E., Wagner B. D., Zerbe G. O., Soti F., Kem W. R., Initial phase 2 trial of a nicotinic agonist in schizophrenia. The American Journal of Psychiatry 2008 165 8 1040 1047 2-s2.0-48949099564 10.1176/appi.ajp.2008.07071135
10. Scarr E., Muscarinic receptors: their roles in disorders of the central nervous system and potential as therapeutic targets. CNS Neuroscience & Therapeutics 2012 18 5 369 379 2-s2.0-84860315449 10.1111/j.1755-5949.2011. 00249.x
11. Gold P. E., Acetylcholine modulation of neural systems involved in learning and memory. Neurobiology of Learning and Memory 2003 80 3 194 210 2-s2.0-0141522452 10.1016/j.nlm.2003.07.003 (Pubitemid 37159348)
12. Perry E., Walker M., Grace J., Perry R., Acetylcholine in mind: a neurotransmitter correlate of consciousness? Trends in Neurosciences 1999 22 6 273 280 2-s2.0-0033018477 10.1016/S0166-2236(98)01361-7 (Pubitemid 29259995)
13. Shekhar A., Potter W. Z., Lightfoot J., Lienemann J., Dubé S., Mallinckrodt C., Bymaster F. P., McKinzie D. L., Felder C. C., Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia. The American Journal of Psychiatry 2008 165 8 1033 1039 2-s2.0-48949095543 10.1176/appi.ajp.2008.06091591
14. Fine A., Hoyle C., Maclean C. J., LeVatte T. L., Baker H. F., Ridley R. M., Learning impairments following injection of a selective cholinergic immunotoxin, ME20.4 IgG-saporin, into the basal nucleus of Meynert in monkeys. Neuroscience 1997 81 2 331 343 2-s2.0-0031559952 10.1016/S0306-4522(97)00208-X (Pubitemid 27381991)
15. Miranda M. I., Bermúdez-Rattoni F., Reversible inactivation of the nucleus basalis magnocellularis induces disruption of cortical acetylcholine release and acquisition, but not retrieval, of aversive memories. Proceedings of the National Academy of Sciences of the United States of America 1999 96 11 6478 6482 2-s2.0-0033065329 10.1073/pnas.96.11.6478 (Pubitemid 29256691)
16. Bucci D. J., Holland P. C., Gallagher M., Removal of cholinergic input to rat posterior parietal cortex disrupts incremental processing of conditioned stimuli. The Journal of Neuroscience 1998 18 19 8038 8046 2-s2.0-0032189611 (Pubitemid 28441041)
17. Sarter M., Bruno J. P., Cognitive functions of cortical acetylcholine: toward a unifying hypothesis. Brain Research Reviews 1997 23 1-2 28 46 2-s2.0-0031040861 10.1016/S0165-0173(96)00009-4 (Pubitemid 27090748)
18. Lucas-Meunier E., Fossier P., Baux G., Amar M., Cholinergic modulation of the cortical neuronal network. Pflugers Archiv 2003 446 1 17 29 2-s2.0-0038637700 (Pubitemid 36539528)
19. Newman M. B., Nazian S. J., Sanberg P. R., Diamond D. M., Shytle R. D., Corticosterone-attenuating and anxiolytic properties of mecamylamine in the rat. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2001 25 3 609 620 2-s2.0-0035037920 10.1016/S0278-5846(00)00178-0 (Pubitemid 32391541)
20. López J. F., Akil H., Watson S. J., Neural circuits mediating stress. Biological Psychiatry 1999 46 11 1461 1471 10.1016/S0006-3223(99)00266-8
21. Terry A. V. Jr., Mahadik S. P., Time-dependent cognitive deficits associated with first and second generation antipsychotics: cholinergic dysregulation as a potential mechanism. Journal of Pharmacology and Experimental Therapeutics 2007 320 3 961 968 2-s2.0-33847145927 10.1124/jpet.106.106047 (Pubitemid 46294039)
22. Sarter M., Nelson C. L., Bruno J. P., Cortical cholinergic transmission and cortical information processing in schizophrenia. Schizophrenia Bulletin 2005 31 1 117 138 2-s2.0-20844438007 10.1093/schbul/sbi006 (Pubitemid 41214362)
23. Ellenbroek B. A., de Bruin N. M., van den Kroonenburg P. T., van Luijtelaar E. L., Cools A. R., The effects of early maternal deprivation on auditory information processing in adult wistar rats. Biological Psychiatry 2004 55 7 701 707 2-s2.0-1642303898 10.1016/j.biopsych.2003.10.024 (Pubitemid 38376181)
24. Mićić D. V., Petronijević N. D., Acetylcholinesterase activity in the Mongolian gerbil brain after acute poisoning with aluminum. Journal of Alzheimer's Disease 2000 2 1 1 6 2-s2.0-0343673822 (Pubitemid 30353512)
25. Mićić D. V., Petronijević N. D., Vucetić S. S., Superoxide dismutase activity in the mongolian gerbil brain after acute poisoning with aluminum. Journal of Alzheime's Disease 2003 5 1 49 56 2-s2.0-0037305137 (Pubitemid 36422851)
26. Whittaker V. P., Barker L. A., The subcellular fractionation of brain tissue with special reference to the preparation of synaptosomes and their component organelles. Methods in Neurochemistry 1972 2 New York, NY, USA Marcel Dekker 1 52
27. Irintchev A., Rollenhagen A., Troncoso E., Kiss J. Z., Schachner M., Structural and functional aberrations in the cerebral cortex of tenascin-C deficient mice. Cerebral Cortex 2005 15 7 950 962 2-s2.0-20544460672 10.1093/cercor/bhh195 (Pubitemid 40848064)
28. Jiao Y., Sun Z., Lee T., Fusco F. R., Kimble T. D., Meade C. A., Cuthbertson S., Reiner A., A simple and sensitive antigen retrieval method for free-floating and slide-mounted tissue sections. Journal of Neuroscience Methods 1999 93 2 149 162 2-s2.0-0032776743 10.1016/S0165-0270(99)00142-9
29. Morgan C. J., Mofeez A., Brandner B., Bromley L., Curran H. V., Acute effects of ketamine on memory systems and psychotic symptoms in healthy volunteers. Neuropsychopharmacology 2004 29 1 208 218 2-s2.0-0347318197 10.1038/sj.npp.1300342 (Pubitemid 38068031)
30. Tandon R., Greden J. F., Cholinergic hyperactivity and negative schizophrenic symptoms. A model of cholinergic/dopaminergic interactions in schizophrenia. Archives of General Psychiatry 1989 46 8 745 753 2-s2.0-0024321406 (Pubitemid 19198101)
31. Zierhut K. C., Schulte-Kemna A., Kaufmann J., Steiner J., Bogerts B., Schiltz K., Distinct structural alterations independently contributing to working memory deficits and symptomatology in paranoid schizophrenia. Cortex 2013 49 4 1063 1072 10.1016/j.cortex.2012.08.027
32. Drusch K., Lowe A., Fisahn K., Brinkmeyer J., Musso F., Mobascher A., Warbrick T., Shah J., Ohmann C., Winterer G., Wölwer W., Effects of nicotine on social cognition, social competence and self-reported stress in schizophrenia patients and healthy controls. European Archives of Psychiatry and Clinical Neuroscience 2013 263 6 519 527 10.1007/s00406-012-0377-9
33. Bencherif M., Stachowiak M. K., Kucinski A. J., Lippiello P. M., Alpha7 nicotinic cholinergic neuromodulation may reconcile multiple neurotransmitter hypotheses of schizophrenia. Medical Hypotheses 2012 78 5 594 600 2-s2.0-84859270307 10.1016/j.mehy.2012.01.035
34. Katerina Z., Andrew K., Filomena M., Xu-Feng H., Investigation of M1/M4 muscarinic receptors in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression disorder. Neuropsychopharmacology 2004 29 3 619 625 2-s2.0-1642415654 10.1038/sj.npp.1300367 (Pubitemid 38365940)
35. Newell K. A., Zavitsanou K., Jew S. K., Huang X.-F., Alterations of muscarinic and GABA receptor binding in the posterior cingulate cortex in schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2007 31 1 225 233 2-s2.0-33845683345 10.1016/j.pnpbp.2006.07.004 (Pubitemid 44959255)
36. Gibbons A. S., Scarr E., Boer S., Money T., Jeon W. J., Felder C., Dean B., Widespread decreases in cortical muscarinic receptors in a subset of people with schizophrenia. The International Journal of Neuropsychopharmacology 2013 16 1 37 46 10.1017/S1461145712000028
37. Barak S., Modeling cholinergic aspects of schizophrenia: focus on the antimuscarinic syndrome. Behavioural Brain Research 2009 204 2 335 351 2-s2.0-69249214135 10.1016/j.bbr.2009.04.006
38. 1 muscarinic acetylcholine receptor: improving cognition and a potential treatment for schizophrenia and Alzheimer's disease. Drug Discovery Today 2013 18 23-24 1185 1199 10.1016/j.drudis.2013.09. 005
39. Young J. W., Geyer M. A., Evaluating the role of the alpha-7 nicotinic acetylcholine receptor in the pathophysiology and treatment of schizophrenia. Biochemical Pharmacology 2013 86 8 1122 1132 10.1016/j.bcp.2013.06.031
40. Hanania T., Johnson K. M., Regulation of NMDA-stimulated [ 14 C ] GABA and [ 3 H ] cetylcholine release by striatal glutamate and dopamine receptors. Brain Research 1999 844 1-2 106 117 2-s2.0-0032861469 10.1016/S0006-8993(99) 01869-7 (Pubitemid 29490957)
41. Mouri A., Noda Y., Enomoto T., Nabeshima T., Phencyclidine animal models of schizophrenia: approaches from abnormality of glutamatergic neurotransmission and neurodevelopment. Neurochemistry International 2007 51 2-4 173 184 2-s2.0-34547459107 10.1016/j.neuint.2007.06.019 (Pubitemid 47176714)
42. du Bois T. M., Newell K. A., Han M., Deng C., Huang X.-F., Perinatal PCP treatment alters the developmental expression of prefrontal and hippocampal muscarinic receptors. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2009 33 1 37 40 2-s2.0-58149333627 10.1016/j.pnpbp.2008.10.001
43. Zugno A. I., de Miranda I. M., Budni J., Volpato A. M., Luca R. D., Deroza P. F., de Oliveira M. B., Heylmann A. S., Silveira F. D. R., Wessler P., Mastella G. A., Cipriano A.L., Quevedo J., Efect of maternal deprivation on acetylcholinesterase activity and beahvioral changes on the ketamine-induced animal model of schizophrenia. Neuroscience 2013 248 252 260 10.1016/j.neuroscience.2013.05.059
44. Soreq H., Seidman S., Acetylcholinesterase-new roles for an old actor. Nature Reviews Neuroscience 2001 2 4 294 302 2-s2.0-0035320772 10.1038/35067589 (Pubitemid 33673070)
45. Dong H., Xiang Y.-Y., Farchi N., Ju W., Wu Y., Chen L., Wang Y., Hochner B., Yang B., Soreq H., Lu W.-Y., Excessive expression of acetylcholinesterase impairs glutamatergic synaptogenesis in hippocampal neurons. The Journal of Neuroscience 2004 24 41 8950 8960 2-s2.0-5644244190 10.1523/JNEUROSCI.2106-04. 2004 (Pubitemid 39372240)
46. Nijholt I., Farchi N., Kye M., Sklan E. H., Shoham S., Verbeure B., Owen D., Hochner B., Spiess J., Soreq H., Blank T., Stress-induced alternative splicing of acetylcholinesterase results in enhanced fear memory and long-term potentiation. Molecular Psychiatry 2004 9 2 174 183 2-s2.0-10744223484 10.1038/sj.mp.4001446 (Pubitemid 38299531)
47. Karam C. S., Ballon J. S., Bivens N. M., Freyberg Z., Girgis R. R., Lizardi-Ortiz J. E., Markx S., Lieberman J. A., Javitch J. A., Signaling pathways in schizophrenia: emerging targets and therapeutic strategies. Trends in Pharmacological Sciences 2010 31 8 381 390 2-s2.0-77955274106 10.1016/j.tips.2010.05.004
48. Moghaddam B., Jackson M. E., Glutamatergic animal models of schizophrenia. Annals of the New York Academy of Sciences 2003 1003 131 137 2-s2.0-0347091934 10.1196/annals.1300.065 (Pubitemid 38083051)
49. Benetti S., Mechelli A., Picchioni M., Broome M., Williams S., McGuire P., Functional integration between the posterior hippocampus and prefrontal cortex is impaired in both first episode schizophrenia and the at risk mental state. Brain 2009 132 9 2426 2436 2-s2.0-70349571012 10.1093/brain/awp098
50. Brown R. W., Beale K. S., Frye G. D. J., Mecamylamine blocks enhancement of reference memory but not working memory produced by post-training injection of nicotine in rats tested on the radial arm maze. Behavioural Brain Research 2002 134 1-2 259 265 2-s2.0-0037151279 10.1016/S0166-4328(02)00047-5 (Pubitemid 34912705)
51. Giacobini E., Cholinesterase inhibitors: new roles and therapeutic alternatives. Pharmacological Research 2004 50 4 433 440 2-s2.0-4043074138 10.1016/j.phrs.2003.11.017 (Pubitemid 39078534)